Intelligence

#High throughput screening #Picodroplet technology #Single-cell analysis

Unlock the power of multiplexing for high-throughput single-cell analysis and isolation

Discover Cyto-Mine® Chroma and picodroplet technology for advanced single-cell analysis: Multiplexing: Simultaneously detect and isolate rare secreting cells using secreted and cellular markers. Ultra-High-Throughput: Efficiently process and sort millions of cells with high accuracy. Cell viability: Maintain high viability and accuracy using complex assays. Download the Application Note to transform… Read More

#Resources

#Antibodies #Bispecific Antibodies #Monoclonal antibodies #Therapeutic Antibodies

The Discovery and Evolution of Antibody Formats

As antibody therapeutics evolve, new formats such as bispecific antibodies (bsAbs) and Fab fragments offer new and exciting therapeutic opportunities. However, traditional mAb isolation methods are often ineffective, necessitating innovative solutions. This article explores these challenges and introduces Astrea Bioseparations’ Fabsorbent™ F1P HF as an alternative strategy for isolating next-generation… Read More

#Resources

#2025 predictions #Drug development #Drug discovery #Regulatory

New modalities: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy, diagnostics and regulation and drug policy. This is the final… Read More

#Exclusive Content #Regulatory #Trends & Analysis

Researcher in a medical lab
#Acute inflammatory conditions #Curlew Bio #Start-ups #University of Queensland

UQ biotech start-up will target a novel immunological pathway

A new start-up aimed at discovering and developing anti-inflammatory disease medicines has been formed by The University of Queensland’s commercialisation arm UniQuest and global biotech company Molecule to Medicine (MTM).  Curlew Bio will leverage expertise from the Queensland Emory and Drug Discovery Initiative (QEDDI) and research developed… Read More

#News #Start-up Zone

Neuroscience
#Neurodegenerative disorders #Neuroscience #Protein degradation #Start-ups #TRIMTECH Therapeutics

Start-up harnesses protein degradation for neurodegeneration

TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, has closed a $31 million seed funding round.   The investment will support further development of the company’s pipeline of central nervous system (CNS) penetrant therapeutics based on its aggregate-selective degrader molecules… Read More

#Business & Investment #News #Start-up Zone

Antibody drug conjugate
#Antibody drug conjugate (ADC) #Callio Therapeutics #Financing #Oncology #Start-ups

$187m supports a new generation of ADC therapies

Biotechnology company Callio Therapeutics has announced its launch with the closing of a $187 million Series A financing round.   Callio is focused on realising the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy.  The newly formed company, with headquarters in Seattle and Singapore,… Read More

#Business & Investment #Cancer Research #News #Start-up Zone

#Artificial intelligence (AI) #Data management #Drug development #Drug discovery

Unifying Data Sources: A Guide for Efficient, Comprehensive Research

In ‘Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery’, we explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies Utilising search alerts Effectively employing AI Read our ebook to learn how you can accelerate your breakthroughs in drug discovery. Read More

#Resources

#Drug discovery

eBook: Unifying Data Sources: A Guide for Efficient, Comprehensive Research

In “Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery,” we explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies  Utilising search alerts  Effectively employing AI Read our ebook to learn how you can accelerate your breakthroughs in drug discovery. … Read More

#eBooks

#2025 predictions #Drug development #Drug discovery #Regulatory

Regulation and drug policy: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy and diagnostics. Here, looking at regulation and drug policy.  Ariel… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Therapeutic Antibodies

Digital Article: The Discovery and Evolution of Antibody Formats

As antibody therapeutics evolve, new formats such as bispecific antibodies (bsAbs) and Fab fragments offer new and exciting therapeutic opportunities. However, traditional mAb isolation methods are often ineffective, necessitating innovative solutions. This article explores these challenges and introduces Astrea Bioseparations’ Fabsorbent™ F1P HF as an alternative strategy for isolating next-generation… Read More

#Digital Articles

Rare diseases
#Data #Rare disease #Rare Disease Day

Rare disease research is changing, data says

This Rare Disease Day, Elsevier’s Scopus research and citation database analyses articles from millions of researchers, institutions and companies around the world to present data that suggests rare disease research has skyrocketed over the last ten years, but is starting to level off. According to the data, there was a… Read More

#News #Trends & Analysis

#Drug discovery

App Note: Unlock the Power of Multiplexing for High-Throughput Single-Cell Analysis and Isolation

Discover Cyto-Mine® Chroma and picodroplet technology for advanced single-cell analysis: Multiplexing: Simultaneously detect and isolate rare secreting cells using secreted and cellular markers. Ultra-High-Throughput: Efficiently process and sort millions of cells with high accuracy. Cell viability: Maintain high viability and accuracy using complex assays. Download the application note to transform… Read More

#App Notes